All articles by GBI Research
GBI Research
More doctors are connecting with patients via social media
Based on recent studies, an estimated 88% of physicians use the web and social media to look into pharmaceutical, biotech, and medical devices, whereas 76% of physicians are utilising mobile devices in their place of practice.
How will GP surgery closures affect the UK?
GP leaders are warning over 2 million patients around the UK that their family doctors could leave their profession as workloads become untenable.
NICE warns of overprescribing antibiotics for pulmonary disease
NICE has released a draft guidance to restrict antibiotic use in patients diagnosed with chronic obstructive pulmonary disease (COPD).
An Apple a day keeps the doctor away
Apple’s decision to provide healthcare services to its staff is another instance of large companies taking on roles that typically belong to the state.
The UK’s postcode lottery for IVF
A total of 13 regions of England have restricted and, in extreme cases, completely halted in vitro fertilisation (IVF) treatment over the past year, in what is being referred to as a postcode lottery.
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Can tech companies disrupt American healthcare?
In the past few weeks tech companies like Amazon, Apple and Google have announced their intentions to enter the American healthcare industry, in an attempt to reduce ever-increasing healthcare costs and improve services for their employees.
Are pharmacists the GPs of the future?
The UK is struggling to keep up with the growing number of patients at local GP surgeries.
NHS funding: why is more government support needed?
At the Health and Care Innovation Expo, Simon Stevens called on the government to increase funding for the NHS, in order to address increasing demand and ever-rising costs.
Healthcare-associated gram-negative infections expected to increase
Diagnosed incident cases of healthcare-associated gram-negative infections is expected to increase between 2016 and 2026 in the seven major markets (7MM) of the US, France, Germany, Italy, Spain, the UK and Japan.
Burden of type 2 diabetes continuing to grow
Diabetes is one of the major non-communicable diseases globally. There are an estimated 450 million people with diabetes aged 20-79 years, including both diagnosed and undiagnosed cases. Undiagnosed diabetes is a major concern, as it often creates an additional socio-economic burden on a country’s healthcare system.